Insights

Insights on digital supply chain transformation

Sign up for the Controlant newsletter

Keep up with developments in pharma supply chain visibility. Sign up for Controlant Insights and receive our latest white paper.

News

Results of Controlant’s Annual General Meeting - 5 May 2025

Controlant reports 2024 results, announces new board members and roadmap toward profitability in 2025 Kópavogur, Iceland, 5 May 2025 — Controlant hf., a global leader in real-time supply chain visibility solutions for the pharmaceutical industry, held its Annual General Meeting (AGM) today. All proposals of the Board of Directors to the meeting were approved. The Company’s financial results for 2024 and outlook for 2025 were presented and two new board members were elected.

Insight

Disrupting the pharma supply chain with IoT

In their keynote at LogiPharma EU in April 2025, Gísli Herjólfsson (Controlant Co-CEO) and Dino Liquito (Global Logistics Business Partner at Roche) discussed the impact of disruptive technology, such as the Saga Card, and shared insights into the urgency of implementing real-time visibility, with IoT already transforming end-to-end supply chain configuration and transparency.

News

Controlant raises its CDP rating with progress on climate issues

Controlant’s coordinated action on climate issues has been awarded a B rating by the Climate Disclosure Project (CDP). The rating marks an improvement from last year’s B- rating and highlights the company’s steadfast progress toward a low-carbon economy.

Insight

How to avoid 16,700t CO2e – a case study with Controlant and Vodafone

A groundbreaking case study conducted by the Carbon Trust, in collaboration with Controlant and Vodafone, highlights the transformative potential of real-time monitoring in pharmaceutical supply chains.

News

Controlant strengthens executive leadership and simplifies operating model to drive growth

Following the successful closing of a $35 million funding round, Controlant today announced changes to its executive leadership as well as a simplification of the operating model to improve execution power and reduce costs.

News

Controlant closes a $35 million funding round to advance market expansion and strategic product development

Controlant announces that it has successfully completed a $35 million financing round to seize opportunities in the ongoing digital transformation of pharma supply chains. The funding consists of $25 million in equity raised by new investors and current shareholders as well as a $10 million debt facility.